Visa buys BioCatch for $2.4 billion to stop fraud earlier

Visa will pay $2.4 billion to acquire BioCatch, adding behavioral-biometric technology to its fraud and cybersecurity portfolio. The deal is aimed at identifying suspicious activity before a payment is completed, rather than relying only on transaction-level signals after the fact.

How BioCatch detects fraud

BioCatch analyzes a user’s behavior, device and network activity in real time to distinguish legitimate customers from attackers. Its machine-learning models examine thousands of signals, including:

• Keyboard-typing patterns
• Mouse movements and touchscreen gestures
• How a user interacts with a device
• Indicators that someone may be acting under pressure

The system is designed to detect account takeovers, scams, use of money mules and other forms of financial crime before the transaction finishes. That makes it particularly relevant to fraud where a customer is authenticated but has been manipulated into authorizing a payment.

Recommended reading

Zenity raises $125M to secure autonomous AI agents

According to BioCatch, its technology analyzes about 19 billion online-banking sessions each month, protecting 760 million users across 1.8 billion devices. The company, founded in 2011, works with more than 350 financial institutions in 21 countries, including over 100 of the world’s largest banks.

Visa’s fraud-security expansion

Following regulatory approvals and other required conditions, the acquisition is expected to close by the end of Visa’s second quarter of fiscal 2027. Visa plans to integrate BioCatch into its existing tools for cybersecurity, risk management and fraud prevention.

Visa said it has invested more than $13 billion over the past five years in technology and infrastructure to protect the payments ecosystem. The acquisition also follows a broader push by payment companies to buy specialized fraud technology: Mastercard acquired Recorded Future for $2.65 billion in 2024, while Visa bought fraud-prevention company Featurespace that same year.

BioCatch is available to US and European financial institutions. It operates in North America, including through a New York office, and lists US bank customers and case studies. It also has an EMEA presence in London and references UK and EU customers including Barclays and HSBC.

Pricing and alternatives

BioCatch does not publish a public list price in US dollars or euros. It sells through enterprise custom quotes, and it has not disclosed whether pricing is based on users, transactions or another package—or whether Visa will change that commercial model after the acquisition.

Enterprise buyers can also evaluate Featurespace, NuData, a Mastercard company, and Pindrop. None of those alternatives has a public list price in the supplied market information either.

The $2.4 billion price signals that Visa sees behavioral analysis as a major layer of payment protection, but the deal’s practical value for banks will depend on how BioCatch is packaged inside Visa’s broader platform and what it ultimately costs customers.